Suchergebnisse - (Person:"Thompson, John L")

PubPharm (170)

31

Left atrial volume and cardiovascular outcomes in systolic heart failure : effect of antithrombotic treatment

enthalten in: ESC heart failure | 2018

von Di Tullio, M. | Qian, M. | Thompson, J. | +17

32

Development of a novel observer reported outcome tool as the primary efficacy outcome measure for a rare disease randomized controlled trial

enthalten in: Mitochondrion | 2018

von Stacpoole, P. | Shuster, J. | Thompson, J. | +5

33

Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)

enthalten in: The American journal of cardiology | 2018

von Lee, T. | Qian, M. | Lip, G. | +20

34

Retrospective natural history of thymidine kinase 2 deficiency

enthalten in: Journal of medical genetics | 2018

von Garone, C. | Taylor, R. | Nascimento, A. | +40

35

Diagnostic odyssey of patients with mitochondrial disease : Results of a survey

enthalten in: Neurology. Genetics | 2018

von Grier, J. | Hirano, M. | Karaa, A. | +2

36

Mitochondrial disease patient motivations and barriers to participate in clinical trials

enthalten in: PloS one | 2018

von Zolkipli-Cunningham, Z. | Xiao, R. | Stoddart, A. | +8

37

International Workshop: : Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy

enthalten in: Neuromuscular disorders : NMD | 2017

von Mancuso, M. | McFarland, R. | Klopstock, T. | +33

38

Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients : From the WARCEF Trial

enthalten in: JACC. Heart failure | 2017

von Teerlink, J. | Qian, M. | Bello, N. | +16

CommentIn: JACC Heart Fail. 2017 Aug;5(8):611-614. - PMID 28774397

39

Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure

enthalten in: Cerebrovascular diseases (Basel, Switzerland) | 2017

von Nakanishi, K. | Di Tullio, M. | Qian, M. | +18

40

Response by Di Tullio et al to Letter Regarding Article, "Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure : Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial"

enthalten in: Stroke | 2016

von Di Tullio, M. | Thompson, J. | Homma, S. | +1

CommentOn: Stroke. 2016 Aug;47(8):2031-7. - PMID 27354224